Cancer News
E-cigarettes may not be helping cancer patients quit smoking
E-cigarettes may not be helping cancer patients to quit smoking, based on a new study.
Chemotherapy added to radiation does not help vulvar cancer treatment
The addition of chemotherapy to post-surgical radiation treatment is not effective in treating vulvar cancer according to the latest research.
Endocrine therapy in some hormone receptor positive breast cancer patients
Older HR+ breast cancer patients with small tumors may have similar benefit from radiation therapy alone, without combining it with endocrine therapy.
Aggressive treatment for some stage 4 lung cancer patients improves survival
Aggressive treatment benefits some "low risk" stage 4 non-small cell lung cancer (NSCLC) patients in terms of overall survival.
Advanced pancreatic cancer combination treatment shows promise
Chemotherapy combined with a stereotactic ablative radiation (SABR) may be a promising treatment option for locally advanced pancreatic cancer patients.
Fertility preservation in male childhood cancer patients
A study has found the chemotherapy dose level, below which male childhood cancer survivors are likely to have normal sperm production.
Lymphedema risk and radiotherapy in node negative breast cancer patients
According to a secondary analysis of a large trial, radiation therapy does not increase the risk of lymphedema in patients with node-negative breast cancer.
The impact of prostate cancer treatments on urinary and sexual functioning
Researchers analyzed the impact of prostate cancer treatment on urinary and sexual functioning to understand how each different option affects patients.
Hodgkin's disease patients benefit from radiation therapy
Stage 1 & 2 Hodgkin's Disease patients who receive consolidated radiation therapy have a higher 10-year survival rate of 84% vs 76% for patients who did not.
Lung cancer patients benefit from radiation and traditional treatment
Advanced small cell lung cancer patients may benefit from radiation combined with conventional treatment in terms of long-term survival and disease recurrence.
Could a breath test detect lung cancer?
Genetic changes can be detected in the vapor given off by cells engineered to mimic the early stages of lung cancer, and could be used to build a breath test.
Combined therapy benefits liver cancer patients not suitable for surgery
A trial has shown that patients with inoperable advanced hepatocellular carcinoma (HCC) may be able to live significantly longer through a combined therapy.
Advanced prostate cancer drug approved by the FDA
The US FDA has approved the oral drug enzalutamide (trade name: Xtandi), for treating advanced prostate cancer in men who have not yet received chemotherapy.
Study: wearing a bra does not increase breast cancer risk
A new study showed that post-menopausal women's risk of breast cancer does not increase because of wearing a bra.
Breast conserving therapy may have better outcomes than mastectomy
Patients with early-stage, hormone receptor-positive (HR+) breast cancer may benefit more from breast-conserving therapy compared to mastectomy.
Saving ovaries during chemotherapy for breast cancer: mixed results
A substance added to chemotherapy for breast cancer patients had a non-significant increase in pregnancies, and resumption of menstruation, in a clinical trial.
Drug for advanced melanoma approved by the US FDA
The US FDA has approved Pembrolizumab (trade name: Keytruda) for treating advanced or unresectable melanoma in patients not responding to other therapies.
Non-Hodgkin Lymphoma risk factors analyzed in international study
Researchers quantified the risk for non-Hodgkin Lymphoma from medical history, lifestyle factors, family history of blood or lymph-related cancers & occupation.
Double mastectomy and reconstruction cause more complications than single operation
Breast cancer patients undergoing double and single mastectomy with reconstruction have higher rates of implant loss, transfusion needs & longer hospital stay.
Bladder cancer: invisible blood in urine may be early warning sign
New research found that invisible blood in urine may be an early warning sign of bladder cancer. This may shape guidelines for how doctors diagnose the disease.
Risk of common skin cancer increased by 90% by sunbeds
New research shows that the risk of squamous cell carcinoma (the second most common type of skin cancer) increases by as much as 90% by sunbeds.
Childhood cancer death rates drop by more than 20% in 10 years in the UK
The rate of children dying from cancer has dropped by 22% in the last decade, according to new figures published by Cancer Research UK.
New, personalized treatment reduces radiation therapy duration
A new approach to treating cancer can deliver personalized radiation therapy during surgery, reducing duration of radiation after surgery & healthy tissue risk.
Three nutrients may reduce prostate cancer risk
A study found that men who follow a diet with selenium, calcium and foods rich in lycopene (an antioxidant found in tomatoes) have a lower prostate cancer risk.
For prostate cancer patients, active surveillance is a valid option
Recommendations for active surveillance, which may help low-risk prostate cancer patients avoid the potentially harmful treatment side effects, have been published.
3 in 4 depressed cancer patients do not get depression treatment
Recent studies reveal that around 75% of cancer patients with major depression are not receiving treatment for it. A new program can improve quality of life.
Modern technology can increase lung cancer detection rates to 90%
A study in Norway showed that current X-ray examinations detect only 20% of lung cancer cases. With modern, ultra-low-dose CT scans, this improved to 90%.
Metastatic colorectal patients benefit from cetuximab vs bevacizumab
Patients with a specific type of metastatic colorectal cancer ("KRAS exon 2 wild type") achieved longer overall survival by receiving cetuximab vs bevacizumab.
Genetic tumor testing recommended for colorectal cancer patients
Up to 25% of colorectal cancer patients in the USA have familial risk. A new guideline recommends genetic testing for all patients newly diagnosed with the disease.
Two new genes may be related to breast cancer: PALB2 & MEN1
Breast cancer risk increased by 5-9 times in women with mutations in the PALB2 gene, investigators reported. Increased risk is suspected for the MEN1 gene too.